Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection‐free allograft survival |
| |
Authors: | Marc A. Soares Jonathan P. Massie William J. Rifkin Nakul Rao April M. Duckworth Chin Park Rohini L. Kadle Joshua A. David Piul S. Rabbani Daniel J. Ceradini |
| |
Affiliation: | NYU Langone Health, Hansj?rg Wyss Department of Plastic Surgery, New York, NY, USA |
| |
Abstract: | Current pharmacologic regimens in transplantation prevent allograft rejection through systemic recipient immunosuppression but are associated with severe morbidity and mortality. The ultimate goal of transplantation is the prevention of allograft rejection while maintaining recipient immunocompetence. We hypothesized that allografts could be engineered ex vivo (after allotransplant procurement but before transplantation) by using mesenchymal stem cell–based therapy to generate localized immunomodulation without affecting systemic recipient immunocompetence. To this end, we evaluated the therapeutic efficacy of bone marrow–derived mesenchymal stem cells in vitro and activated them toward an immunomodulatory fate by priming in inflammatory or hypoxic microenvironments. Using an established rat hindlimb model for allotransplantation, we were able to significantly prolong rejection‐free allograft survival with a single perioperative ex vivo infusion of bone marrow–derived mesenchymal stem cells through the allograft vasculature, in the absence of long‐term pharmacologic immunosuppression. Critically, transplanted rats rejected a second, nonengineered skin graft from the same donor species to the contralateral limb at a later date, demonstrating that recipient systemic immunocompetence remained intact. This study represents a novel approach in transplant immunology and highlights the significant therapeutic opportunity of the ex vivo period in transplant engineering. |
| |
Keywords: | animal models: murine basic (laboratory) research/science immunosuppression/immune modulation organ transplantation in general rejection stem cells tolerance: experimental tolerance: mechanisms translational research/science vascularized composite and reconstructive transplantation |
|
|